Article
Granulocyte/macrophage-colony stimulating factor and interleukin-4 expand and activate type-1 dendritic cells (DC1) when administered in vivo to cancer patients.
International journal of cancer - 1 Nov 2003
Kiertscher Sylvia M, Gitlitz Barbara J, Figlin Robert A, Roth Michael D
Abstract excerpt
Two rare populations of cells with the features of dendritic cell precursors (preDC) can be identified in human peripheral blood. PreDC1 are HLA-DR+/CD11c+ cells which mature into DC1 capable of stimulating Th1 responses. In contrast, preDC2 are HLA-DR+/CD11c-/CD123+ cells that promote Th2 responses when matured into DC2. We hypothesized that administration of GM-CSF and IL-4, growth factors for DC1, would...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
